Neurocrine Biosciences, Inc. (NBIX)

145.26 -1.67 (-1.14%) USD  |  NASDAQ  |  Dec 26, 16:00
145.16 -0.10 (-0.07%) Pre-Market: 20:00
More

Neurocrine Biosciences Amortization Expense CF (% of Quarterly Assets)

Amortization Expense CF (% of Quarterly Assets) Chart

View Amortization Expense CF (% of Quarterly Assets) for NBIX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Amortization Expense CF (% of Quarterly Assets) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Amortization Expense CF (% of Quarterly Assets) Range, Past 5 Years

View Amortization Expense CF (% of Quarterly Assets) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Amortization Expense CF (% of Quarterly Assets) Benchmarks

View Amortization Expense CF (% of Quarterly Assets) Benchmarks
Start Trial
Pfizer Inc. Upgrade
Masimo Corp. Upgrade
Insulet Corp. Upgrade
Marker Therapeutics, Inc. --
CapsoVision, Inc. --